Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection Doc Wire News, 21 Dec 2021 This article was originally published here Mol Med. 2021 Dec 20;27(1):160. doi: 10.1186/s10020-021-00422-z.